Literature DB >> 18840316

Associations between infectious mononucleosis and cancer: record-linkage studies.

M J Goldacre1, C J Wotton, D G R Yeates.   

Abstract

Infection with Epstein-Barr virus (EBV) followed by infectious mononucleosis (IM) is now considered to be a risk factor for Hodgkin's disease (HD). It is less clear whether EBV infection and IM are associated with an increased risk of cancer generally. We used a longstanding record-linkage dataset in Oxford (years 1963-1998), and a more recent record-linkage dataset covering England (1999-2005), to compare rate ratios for cancer between people admitted to hospital for IM and a reference cohort. In the Oxford cohort, there was an increased risk of subsequent HD [rate ratio (RR) 6.0, 95% confidence interval (CI) 2.4-12.5] but not of other cancers combined (RR 0.85, 95% CI 0.57-1.23). In the England cohort, there were increased risks of HD (RR 3.2, 95% CI 1.2-7.0), non-Hodgkin's lymphoma (RR 5.6, 95% CI 2.9-9.8), and oropharyngeal cancer (RR 5.4, 95% CI 1.1-16.2), but no significant overall risk of cancer when lymphomas were excluded (RR 1.01, 95% CI 0.71-1.41). We confirm an association between IM and lymphoma; but the risk, if any, of cancer more generally is likely to be small.

Entities:  

Mesh:

Year:  2008        PMID: 18840316     DOI: 10.1017/S0950268808001246

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  8 in total

1.  An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA.

Authors:  Sophia Pavlova; Regina Feederle; Kathrin Gärtner; Walter Fuchs; Harald Granzow; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

2.  A virus-like particle-based Epstein-Barr virus vaccine.

Authors:  Romana Ruiss; Simon Jochum; Gerhard Wanner; Gilbert Reisbach; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

3.  A three year Seroepidemiological and molecular study of Epstein -Barr virus infection among different age groups with hematological malignancies in a Tertiary care centre of North India ( 2017 -2019).

Authors:  Sangram Singh Patel; Sweta Singh; Chinmoy Sahu; Ujjala Ghoshal; Hemant Verma
Journal:  J Family Med Prim Care       Date:  2021-01-30

4.  Maternal and perinatal factors associated with hospitalised infectious mononucleosis in children, adolescents and young adults: record linkage study.

Authors:  Imran Mahmud; Omar A Abdel-Mannan; Clare J Wotton; Michael J Goldacre
Journal:  BMC Infect Dis       Date:  2011-02-28       Impact factor: 3.090

5.  Cardiorespiratory fitness and risk of site-specific cancers: a long-term prospective cohort study.

Authors:  Trude E Robsahm; Ragnhild S Falk; Trond Heir; Leiv Sandvik; Linda Vos; Jan Erikssen; Steinar Tretli
Journal:  Cancer Med       Date:  2017-03-20       Impact factor: 4.452

6.  Epstein-Barr virus particles induce centrosome amplification and chromosomal instability.

Authors:  Anatoliy Shumilov; Ming-Han Tsai; Yvonne T Schlosser; Anne-Sophie Kratz; Katharina Bernhardt; Susanne Fink; Tuba Mizani; Xiaochen Lin; Anna Jauch; Josef Mautner; Annette Kopp-Schneider; Regina Feederle; Ingrid Hoffmann; Henri-Jacques Delecluse
Journal:  Nat Commun       Date:  2017-02-10       Impact factor: 14.919

Review 7.  Epstein-Barr virus and its association with disease - a review of relevance to general practice.

Authors:  Anders Fugl; Christen Lykkegaard Andersen
Journal:  BMC Fam Pract       Date:  2019-05-14       Impact factor: 2.497

8.  Acute systemic viral infection masquerading as an infiltrating lymphoma in an elderly patient: a case report and review of the literature.

Authors:  Hani M Babiker; Troy Wiedenbeck; Ryan S Robetorye; Utkarsh Acharya; Susan Wilansky; Shimon Kusne
Journal:  Case Rep Med       Date:  2013-02-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.